Review
Published on 21 Jun 2024
Polymyxins: recent advances and challenges
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1424765
- 4,662 views
- 4 citations
Type at least 3 characters
364 articles
Editorial
Published on 19 Jun 2024
Editorial: Commercialization and industrialization of pharmacology of infectious diseases: 2022
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1438072
- 935 views
Original Research
Published on 18 Jun 2024
Antimalarial and antioxidant activities of novel artesunate-ellagic acid hybrid compound in vitro and in vivo
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1192659
- 1,886 views
- 2 citations
Review
Published on 17 Jun 2024
Current research update on group B streptococcal infection related to obstetrics and gynecology
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1395673
- 4,287 views
- 1 citation
Original Research
Published on 04 Jun 2024
Vancomycin population pharmacokinetics and dosing proposal for the initial treatment in obese adult patients
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1364681
- 1,749 views
Original Research
Published on 04 Jun 2024
Influence of β-lactam pharmacodynamics on the systems microbiology of gram-positive and gram-negative polymicrobial communities
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1339858
- 912 views
Original Research
Published on 30 May 2024
Targeting Leishmania infantum Mannosyl-oligosaccharide glucosidase with natural products: potential pH-dependent inhibition explored through computer-aided drug design
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1403203
- 3,412 views
- 2 citations
Original Research
Published on 30 May 2024
Identification of urine biomarkers predictive of prolonged QTc interval in multidrug-resistant tuberculosis patients treated with bedaquiline
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1362544
- 1,215 views
Systematic Review
Published on 27 May 2024
Therapeutic effects of vitamin D supplementation on COVID-19 aggravation: a systematic review and meta-analysis of randomized controlled trials
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1367686
- 2,521 views
- 4 citations
Review
Published on 20 May 2024
Endolysins: a new antimicrobial agent against antimicrobial resistance. Strategies and opportunities in overcoming the challenges of endolysins against Gram-negative bacteria
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1385261
- 8,039 views
- 14 citations
Original Research
Published on 10 May 2024
Population pharmacokinetics, dosing optimization and clinical outcomes of biapenem in patients with sepsis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1388150
- 1,636 views
Original Research
Published on 09 May 2024
Safety and efficacy evaluation of halicin as an effective drug for inhibiting intestinal infections
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1389293
- 4,310 views
- 2 citations
Editorial
Published on 07 May 2024
Editorial: Combinational therapy and nanotechnologies in combating pathogenic microbes and antibiotic resistance
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1406043
- 820 views
Original Research
Published on 01 May 2024
Comparative efficacy of buparvaquone and imidocarb in inhibiting the in vitro growth of Babesia bovis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1407548
- 2,432 views
- 3 citations
Original Research
Published on 19 Apr 2024
Two promising Bacillus-derived antifungal lipopeptide leads AF4 and AF5 and their combined effect with fluconazole on the in vitro Candida glabrata biofilms
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1334419
- 1,738 views
Original Research
Published on 11 Apr 2024
In vitro pharmacokinetics/pharmacodynamics of FL058 (a novel beta-lactamase inhibitor) combined with meropenem against carbapenemase-producing Enterobacterales
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1282480
- 1,423 views
- 2 citations